Skip to content

Physical Activity Enhancement Using Pedometers in COPD

Effect of a Program of Physical Activity Enhancement Using Pedometers in Chronic Obstructive Pulmonary Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01739751
Enrollment
90
Registered
2012-12-03
Start date
2011-01-31
Completion date
2013-04-30
Last updated
2012-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, Physical activity, Pedometers, steps, non pharmacological treatment, rehabilitation, exercise

Brief summary

Physical activity is reduced in COPD affecting morbidity and mortality and the usual advice is not good enough to increase the physical activity level. The aim of the study is to determine the effects of pedometers in the physical level in COPD patients.

Detailed description

Physical activity is reduced in COPD patients and has a negative effect in the morbidity and mortality of this condition. Unfortunately, usual advice is not good enough to reverse the sedentary condition in COPD patients. Pedometers are broadly used to measure and to enhance physical activity in COPD but their effects in COPD are not well known. The aim of the study is to determine the effects of a program using pedometers as a feedback in stable ex smokers COPD patients. Patients are recruited for a 3 months individual program promoting daily physical activity enhancement and are randomly assigned either to a pedometer-based program (experimental group) or to usual care (control group, the measurements at the beginning and at the end of the study are: anthropometrics, Spirometry, dyspnea, quality of life, exercise capacity and the average one week daily steps. Also the number of acute exacerbations during the follow up are recorded.

Interventions

portable device that estimate the number of steps walked daily

Sponsors

Comisión Nacional de Investigación Científica y Tecnológica
CollaboratorOTHER_GOV
University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD diagnosis according to GOLD guidelines * Pack year Index equal or more than 10 * smoking suspended \> 2 months * older than 40 years old,

Exclusion criteria

* any chronic condition that does not allow walking * participation in a rehabilitation program * Acute exacerbation in the last two months

Design outcomes

Primary

MeasureTime frameDescription
effect in average steps walked daily3 monthsComparison between both groups in the difference of the average of steps walked daily at final evaluation with the basal evaluation

Secondary

MeasureTime frameDescription
six minute walking distance3 monthsComparison between groups in the difference of the distance( meters) in the six minute walking test in the final evaluation with the basal evaluation
score in the Saint George Respiratory Questionnaire3 monthsComparison between groups in the difference of the score of the SGRQ at the final evaluation in comparison with the basal evaluation
Score of the COPD Assessment Test (CAT)3 monthsComparison between groups in the difference of the CAT score at the final evaluation with the basal evaluation

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026